1887
Volume 2025, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Hypothyroidism is commonly associated with obesity. While the effects of bariatric surgery on comorbidities such as type 2 diabetes and hypertension have been well studied, there is limited information regarding its benefits in obese patients diagnosed with and receiving treatment for hypothyroidism.

This study aimed to evaluate the effects of bariatric surgery in patients with hypothyroidism, with particular focus on changes in levothyroxine (LT4) dosage and the prevalence of hypothyroidism remission post-surgery.

A retrospective study spanning seven years was conducted at the Obesity Clinic of KFMC (King Fahad Medical City—a public tertiary care center in Riyadh, Saudi Arabia), involving 163 patients with concurrent obesity and hypothyroidism who underwent bariatric surgery. Patient’s medical charts and pharmacological treatment records were reviewed. Pre- and post-operative parameters, including weight, body mass index (BMI), thyroid status, thyroid-stimulating hormone, free thyroxine, LT4 dosage, and the type of bariatric surgery performed, were recorded. Continuous variables are presented as mean±SD (standard deviation) and as percentages. Student’s t-test was used to analyze the difference between means, and data normality was assessed using the Shapiro–Wilk test.

Of the 163 patients, 14 (8.6%) were male and 149 (91.4%) were female, with an overall mean pre-operative BMI of 49.30 ± 9.49 kg/m2. Prior to surgery, the mean LT4 dose was 118.25 ± 59.39 mcg, which significantly decreased to 83.13 ± 57.39 mcg post-surgery (P < 0.001), reflecting a 30% reduction. Additionally, 24 patients (14.7%) experienced remission from hypothyroidism, whereas 8 patients (4.9%) showed an increase in thyroxine dosage.

The study demonstrated a significant reduction in LT4 doses following bariatric surgery, suggesting that obesity may contribute to hypothyroidism. Bariatric surgery may improve thyroid function, potentially reducing the need for medication. Patients with hypothyroidism undergoing bariatric surgery should have their thyroid function closely monitored every 6–12 weeks post-operatively for 1–2 years, or until their nadir weight is reached, to allow for appropriate levothyroxine dose adjustments.

© 2025 Buhary, Alshehri, Abukhater, Mahmood, Mahmood, licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.102
2025-12-04
2025-12-05

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/4/qmj.2025.102.html?itemId=/content/journals/10.5339/qmj.2025.102&mimeType=html&fmt=ahah

References

  1. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: An intriguing link. Indian J Endocrinol Metab. 2016 Jul-Aug; 20:(4):554–7. https://doi.org/10.4103/2230-8210.183454
     [Google Scholar]
  2. Aurangabadkar G, Kusuma Boddu S. Hypothyroidism and obesity: Is there a bidirectional link? What is the impact on our clinical practice? Thyroid Res Pract. 2020; 17:(3):118. https://doi.org/10.4103/trp.trp_59_20
     [Google Scholar]
  3. Pearce EN. Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes. 2012 Oct; 19:(5):408–13. https://doi.org/10.1097/MED.0b013e328355cd6c
     [Google Scholar]
  4. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al.. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb; 87:(2):489–99. https://doi.org/10.1210/jcem.87.2.8182
     [Google Scholar]
  5. Hoogendoorn EH. Hermus AR, de Vegt F, Ross HA, Verbeek ALM, Kiemeney LALM, et al.. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: Influences of age and sex. Clin Chem. 2006 Jan; 52:(1):104–11. https://doi.org/10.1373/clinchem.2005.055194
     [Google Scholar]
  6. Alruwaili AEM, Alshalan MHF→, Alfuhigi ZDM, Abdulhamid MAA, Alanzi NDY, Alanazi, ANK, et al.. Prevalence of hypothyroidism and its associated risk factors in Arar City, Saudi Arabia. Egypt J Hosp Med. 2018 Apr [cited 2025 Apr 14]; 71:(3):2765–9. https://doi.org/10.12816/0045841
     [Google Scholar]
  7. Chiovato L, Magri F, Carlé A. Hypothyroidism in context: Where we’ve been and where we’re going. Adv Ther. 2019 Sep 4; 36:(Suppl 2):47–58. https://doi.org/10.1007/s12325-019-01080-8
     [Google Scholar]
  8. Åsvold BO, Vatten LJ, Bjøro T. Changes in the prevalence of hypothyroidism: The HUNT study in Norway. Eur J Endocrinol. 2013 Oct 1; 169:(5):613–20. https://doi.org/10.1530/EJE-13-0459
     [Google Scholar]
  9. Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J Clin Endocrinol Metab. 2014 Mar; 99:(3):923–31. https://doi.org/10.1210/jc.2013-2409
     [Google Scholar]
  10. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al.. The spectrum of thyroid disease in a community: The whickham survey. Clin Endocrinol. 1977 Dec; 7:(6):481–93. https://doi.org/10.1111/j.1365-2265.1977.tb01340.x
     [Google Scholar]
  11. Alzahrani AS, Al Mourad M, Hafez K, Almaghamsy AM, Alamri FA, Al Juhani NR, et al.. Diagnosis and management of hypothyroidism in Gulf Cooperation Council (GCC) countries. Adv Ther. 2020 Jul; 37:(7):3097–111. https://doi.org/10.1007/s12325-020-01382-2
     [Google Scholar]
  12. AlAwaji MI, Alhamwy RH. The impact of hypothyroidism on the Quality of Life of Adults in Riyadh, Saudi Arabia. Cureus. 2023 Apr 16; 15:(4):e37636. https://doi.org/10.7759/cureus.37636
     [Google Scholar]
  13. Al Eidan E, Ur Rahman S, Al Qahtani S, Al Farhan AI, Abdulmajeed I. Prevalence of subclinical hypothyroidism in adults visiting primary health-care setting in Riyadh. J Community Hosp Intern Med Perspect. 2018 Feb 6; 8:(1):11–5. https://doi.org/10.1080/20009666.2017.1422672
     [Google Scholar]
  14. Aljabri KSJ, Alnasser IM, Facharatz , Bokhari SA, Alshareef MA, Khan PM, et al.. The frequency of hypothyroidism in Saudi community-based hospital: A retrospective single centre study. Trends Diabetes Metab. 2019; 2:(1). https://doi.org/10.15761/TDM.1000107
     [Google Scholar]
  15. Alqahtiani NM, Alramadhan ZT, Obaid MRB, Kurdi AN, Abdulhameed AF, et al.. Hypothyroidism in Saudi Arabia; prevalence, risk factors, and its relation with diabetes mellitus. Arch Pharm Pract. 2020; 11:(3):56–2.
    [Google Scholar]
  16. Hasanato R, Abbas Mirah J, Shahrani NA, Alfulayyih N, Almutairi A, Ogailan B, et al.. Incidence of thyroid diseases in female Saudi Adults visiting a tertiary care hospital in Riyadh. Epidemiol: Open Access. 2017; 7:(1). https://doi.org/10.4172/2161-1165.1000286
     [Google Scholar]
  17. Gajda SN, Kuryłowicz A, ach M, Bednarczuk T, Wyleoł M. Diagnosis and treatment of thyroid disorders in obese patients – what do we know? Endokrynol Pol. 2019; 70:(3):271–6. https://doi.org/10.5603/EP.a2018.0089
     [Google Scholar]
  18. Kurylowicz A. Endocrine disorders accompanying obesity – effect or cause? In: Rao VRao L, (editors). Role of obesity in human health and disease. 2021 Dec 22. https://doi.org/10.5772/intechopen.98793
     [Google Scholar]
  19. Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, et al.. European Society of endocrinology clinical practice guideline: Endocrine work-up in obesity. Eur J Endocrinol. 2020 Jan 1; 182:(1):G1–32. https://doi.org/10.1530/EJE-19-0893
     [Google Scholar]
  20. Chikunguwo S, Brethauer S, Nirujogi V, Pitt T, Udomsawaengsup S, Chand B, et al.. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis. 2007 Nov–Dec; 3:(6):631–5. https://doi.org/10.1016/j.soard.2007.07.011
     [Google Scholar]
  21. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010 Mar 25; 316:(2):165–71. https://doi.org/10.1016/j.mce.2009.06.005
     [Google Scholar]
  22. Villar HCCE, Saconato H, Valente O, Atallah ÁN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev. 2007 Jul 18; 2007:(3):CD003419. https://doi.org/10.1002/14651858.CD003419.pub2
     [Google Scholar]
  23. Song R, Wang B, Yao Q-M, Li Q, Jia X, Zhang J-A. The impact of obesity on thyroid autoimmunity and dysfunction: A systematic review and meta-analysis. Front Immunol. 2019 Oct 1; 10:: 2349. https://doi.org/10.3389/fimmu.2019.02349
     [Google Scholar]
  24. van Hulsteijn LT, Pasquali R, Casanueva F, Haluzik M, Ledoux S, Monteiro MP, et al.. Prevalence of endocrine disorders in obese patients: Systematic review and meta-analysis. Eur J Endocrinol. 2020 Jan; 182:(1):11–21. https://doi.org/10.1530/EJE-19-0666
     [Google Scholar]
  25. Verma A, Jayaraman M, Kumar HKVS, Modi KD. Hypothyroidism and obesity. Cause or effect? Saudi Med J. 2008 Aug; 29:(8):1135–8.
    [Google Scholar]
  26. Al-Khaldi Y. Bariatric surgery in Saudi Arabia: The urgent need for standards. Saudi J Obes. 2016; 4:(1):1. https://doi.org/10.4103/2347-2618.184930
     [Google Scholar]
  27. Kloock S, Ziegler CG, Dischinger U. Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery? Pharmacol Ther. 2023 Nov: 251:: 108549. https://doi.org/10.1016/j.pharmthera.2023.108549
     [Google Scholar]
  28. Alfaifi HH, Altowairgi MA, Algethami RG, Altowairqi AH, Althomali HD, Almalki OM, et al.. Effectiveness of bariatric surgery for improving thyroid function and reducing levothyroxine dose in patients with obesity and overt hypothyroidism. Cureus. 2023 May 9; 15:(5):e38780. https://doi.org/10.7759/cureus.38780
     [Google Scholar]
  29. Ali M, Khan SA, Mushtaq M, Haider SA. Comparison of laparoscopic sleeve gastrectomy (LSG) with laparoscopic gastric bypass (LRYGB) in bariatric surgery. Cureus. 2021 Mar 21; 13:(3):e14022. https://doi.org/10.7759/cureus.14022
     [Google Scholar]
  30. Khwaja HA, Bonanomi G. Bariatric surgery: Techniques, outcomes and complications. Curr Anaesth Crit Care. 2010 Feb; 21:(1):31–8. https://doi.org/10.1016/j.cacc.2009.10.005
     [Google Scholar]
  31. Felsenreich DM, Bichler C, Langer FB, Gachabayov M, Prager G. Sleeve gastrectomy: Surgical technique, outcomes, and complications. Surg Technol Int. 2020 May 28; 36:: 63–9.
    [Google Scholar]
  32. Almunif DS, Bamehriz F, Althuwaini S, Almigbal TH, Batais MA. The effect of laparoscopic sleeve gastrectomy on serum thyroid-stimulating hormone levels in obese patients with overt and subclinical hypothyroidism: A 7-year retrospective study. Obes Surg. 2020 Apr; 30:(4):1491–7. https://doi.org/10.1007/s11695-019-04337-x
     [Google Scholar]
  33. Rudnicki Y, Slavin M, Keidar A, Kent I, Berkovich L, Tiomkin V, et al.. The effect of bariatric surgery on hypothyroidism: Sleeve gastrectomy versus gastric bypass. Surg Obes Relat Dis. 2018 Sep; 14:(9):1297–303. https://doi.org/10.1016/j.soard.2018.06.008
     [Google Scholar]
  34. Zhu C, Gao J, Mei F, Lu L, Zhou D, Qu S. Reduction in thyroid-stimulating hormone correlated with improved inflammation markers in Chinese patients with morbid obesity undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2019 Dec; 29:(12):3954–65. https://doi.org/10.1007/s11695-019-04063-4
     [Google Scholar]
  35. Azran C, Hanhan-Shamshoum N, Irshied T, Ben-Shushan T, Dicker D, Dahan A, et al.. Hypothyroidism and levothyroxine therapy following bariatric surgery: A systematic review, meta-analysis, network meta-analysis, and meta-regression. Surg Obes Relat Dis. 2021 Jun; 17:(6):1206–17. https://doi.org/10.1016/j.soard.2021.02.028
     [Google Scholar]
  36. Guo F, Bakal K, Minokoshi Y, Hollenberg AN. Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo. Endocrinology. 2004 May; 145:(5):2221–7. https://doi.org/10.1210/en.2003-1312
     [Google Scholar]
  37. Nannipieri M, Cecchetti F, Anselmino M, Camastra S, Niccolini P, Lamacchia M, et al.. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: Effects of weight loss. Int J Obes (Lond). 2009 Sep; 33:(9):1001–6. https://doi.org/10.1038/ijo.2009.140
     [Google Scholar]
  38. Liu S, Ma J, Zhang L, Yang Y, Han Z, Tian L. Circulating leptin levels in thyroid dysfunction: A systematic review and meta-analysis. BMC Endocr Disord. 2025 Jun 6; 25:(1):140. https://doi.org/10.1186/s12902-025-01943-y
     [Google Scholar]
  39. Dharia A, Desai D, Desai K. Exploring the link between thyroid disorders and obesity Mechanisms, impacts, and clinical implications. Endocr Pract. 2025 May; 31:(5):660–7. https://doi.org/10.1016/j.eprac.2025.02.005
     [Google Scholar]
  40. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al.. Sleeve gastrectomy and gastric banding: Effects on plasma ghrelin levels. Obes Surg. 2005 Aug; 15:(7):1024–9. https://doi.org/10.1381/0960892054621125
     [Google Scholar]
  41. Emami A, Nazem R, Hedayati M. Is association between thyroid hormones and gut peptides, ghrelin and obestatin, able to suggest new regulatory relation between the HPT axis and gut? Regul Pept. 2014 Feb 10; 189:: 17–21. https://doi.org/10.1016/j.regpep.2014.01.001
     [Google Scholar]
  42. Zendel A, Abu-Ghanem Y, Dux J, Mor E, Zippel D, Goitein D. The impact of bariatric surgery on thyroid function and medication use in patients with hypothyroidism. Obes Surg. 2017 Aug; 27:(8):2000–4. https://doi.org/10.1007/s11695-017-2616-7
     [Google Scholar]
  43. Najjari K, Talebpour M, Mahmoudabadi HZ, Elyasinia F, Abolhasani M, Ashrafi A, et al.. Effect of laparoscopic sleeve gastrectomy vs. OAGB on thyroid function tests in patients with morbid obesity and subclinical or clinical hypothyroidism. Obes Surg. 2021 Nov; 31:(11):4808–14. https://doi.org/10.1007/s11695-021-05646-w
     [Google Scholar]
  44. Guan B, Chen Y, Yang J, Yang W, Wang C. Effect of bariatric surgery on thyroid function in obese patients: A systematic review and meta-analysis. Obes Surg. 2017 Dec; 27:(12):3292–305. https://doi.org/10.1007/s11695-017-2965-2
     [Google Scholar]
/content/journals/10.5339/qmj.2025.102
Loading
Remission of hypothyroidism in post-bariatric surgery patients
Qatar Medical Journal 2025, 102 (2025); https://doi.org/10.5339/qmj.2025.102
/content/journals/10.5339/qmj.2025.102
/content/journals/10.5339/qmj.2025.102
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): bariatric surgery, Hypothyroidism, obesity, Saudi Arabia and thyroxine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error